Opioid manufacturer Insys files for bankruptcy after $225m settlement

Insys Therapeutics founder and executives were convicted of bribing doctors to prescribe highly addictive painkiller

A leading drug maker, whose founder and top executives have been convicted of bribing doctors to prescribe a highly addictive painkiller, has become the first opioid manufacturer to declare bankruptcy after being hit with huge fines.

On Monday, Insys Therapeutics filed for Chapter 11 bankruptcy protection while it sells off its assets after reaching a $225m settlement with the justice department last week over fraud charges. One of the company’s subsidiaries pleaded guilty to five counts of mail fraud as part of the settlement.

Insys’s founder, John Kapoor, and four former executives are facing lengthy prison sentences after they were convicted last month of bribing doctors to prescribe the company’s opioid spray, Subsys, to patients who did not need it. Subsys is made of fentanyl, an opioid many times stronger than morphine, and was approved for terminal cancer patients. But the company targeted sales at the much larger and more profitable market of people with non-life-threatening chronic pain.

Kapoor oversaw a marketing strategy in which payments to doctors, ostensibly for speeches at educational seminars, were effectively bribes to prescribe the drug. Prosecutors said the seminars were no more than social gatherings at restaurants, bars and strip clubs.

In one instance, the company paid nearly $260,000 to two New York doctors who wrote more than $6m worth of Subsys prescriptions in 2014. Sales of Subsys surged into the hundreds of millions of dollars a year as a result of the company’s aggressive marketing.

The US attorney in Boston who prosecuted Insys, Andrew Lelling, accused the company of “illegal conduct that prioritised its profits over the health of thousands of patients” and of “fuelling the opioid epidemic”.

Before the agreement with the justice department, Insys was facing large legal bills as it fought hundreds of lawsuits alongside other companies accused of fuelling an epidemic that has claimed more than 400,000 lives over the past two decades. They include Purdue Pharma, the maker of the powerful opioid, OxyContin, which kickstarted the crisis.

The multinational drug giant, Johnson & Johnson, is in the midst of a civil trial in Oklahoma where it has been accused of “a cynical, deceitful multimillion-dollar brainwashing campaign” to drive up sales of its powerful painkillers.

Sign up for the US morning briefing

Oklahoma’s attorney general, Mike Hunter, said greed led the company to play a leading role in “the worst manmade health crisis in the history of the country and the state”. Oklahoma is seeking billions of dollars in compensation to help cover the long-term consequences of the opioid epidemic in the state.

A statement by the lead counsels in the combined legal cases of more than 1,800 states, cities and other communities seeking billions of dollars in compensation from 22 opioid manufacturers, distributors and pharmacies, said they would continue to pursue the legal action against Insys to recover the costs of the epidemic on public finances, from increased crime to addiction treatment and care for orphaned children.

“Bankruptcy and restructuring does not necessarily mean that a company is insolvent. Additionally, the goal of the litigation is not to bankrupt these opioid companies, but to abate the current opioid epidemic and seek long-term, sustainable solutions. If any defendant files for bankruptcy, we will work through all legal avenues to see that our clients’ end goal of abating the crisis is met,” they said. “The American public deserves to see the truth behind this epidemic revealed and justice served.”


Chris McGreal

The GuardianTramp

Related Content

Article image
Purdue's opioid settlement set to herald barrage of lawsuits against big pharma
Oklahoma chooses to settle for $270m over Purdue’s criminal marketing of OxyContin – but more lawsuits are likely to come

Chris McGreal in Kansas City

28, Mar, 2019 @5:00 AM

Article image
OxyContin maker Purdue Pharma files for bankruptcy
Move is partly aimed at halting more than 2,000 lawsuits filed against drug firm

Julia Kollewe

16, Sep, 2019 @4:53 AM

Article image
Capitalism gone wrong: how big pharma created America's opioid carnage
A web of firms ramped up narcotic painkiller sales, creating the biggest drug epidemic in American history as profits surged

Chris McGreal

24, Jul, 2019 @6:00 AM

Article image
What does Purdue Pharma's bankruptcy filing actually mean?
What cases is Purdue caught up in and who else is involved and what happens next? Here’s what you need to know

Joanna Walters in New York

19, Sep, 2019 @6:00 AM

Article image
Jonathan Sackler, joint owner of opioid maker Purdue Pharma, dies aged 65
Former pharmaceutical executive, who died of cancer on 30 June, had been named as defendant in key opioid lawsuits

Joanna Walters in New York and agency

06, Jul, 2020 @10:59 PM

Article image
Five more US states sue Purdue Pharma over its role in opioid crisis
Wisconsin, Iowa, Kansas, Maryland and West Virginia join several dozen other states, alleging company pushed false claims

Joanna Walters in New York

16, May, 2019 @9:09 PM

Article image
The woman who turned down her share of a $6bn settlement to fight the family behind the opioid crisis
Ellen Isaacs is intent on holding Purdue Pharma and the Sackler family to account – for the deaths of her son and many thousands of others

Edward Helmore in Floyd, Virginia

10, Apr, 2022 @6:00 AM

Article image
Four big drug firms agree to $260m opioid payout hours before trial set to begin
Teva and three drug distributors confirm last-minute settlement before Ohio trial in which they were to be accused of profiting from addiction and death

Chris McGreal in Cleveland

21, Oct, 2019 @3:44 PM

Article image
Drug makers flooded US with billions of opioid pills as epidemic surged, data shows
Statistics are a blow to country’s biggest pharmaceuticals that paid millions of dollars in out of court settlements

Chris McGreal in Kansas City and Joanna Walters in New York

17, Jul, 2019 @7:27 PM

Article image
Johnson & Johnson boosted opioid sales via 'cynical brainwashing', court hears
Drug giant accused of deceptive marketing conspiracy in civil suit that says J&J was ‘kingpin’ of public health emergency

Chris McGreal in Norman, Oklahoma

28, May, 2019 @10:37 PM